Vor Biopharma annual total assets
2020
2021
2022
2023
2024
2025
Vor Biopharma Total Assets Growth & History (VOR)
Vor Biopharma's total assets was $464.1M for fiscal 2025.
View full Vor Biopharma company overviewVor Biopharma annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $464.1M | $321.2M | +224.81% |
| 2024 | 2024-12-31 | $142.9M | −$55.2M | −27.88% |
| 2023 | 2023-12-31 | $198.1M | −$101.2M | −33.82% |
| 2022 | 2022-12-31 | $299.4M | $56.8M | +23.40% |
| 2021 | 2021-12-31 | $242.6M | $166.7M | +219.58% |
| 2020 | 2020-12-31 | $75.9M | — | — |
Vor Biopharma quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $481.1M | $275.7M | +134.24% |
| Q1 2026 | 2026-03-31 | $506.7M | $397.4M | +363.58% |
| Q4 2025 | 2025-12-31 | $464.1M | $321.2M | +224.81% |
| Q3 2025 | 2025-09-30 | $176.2M | $60.2M | +51.94% |
| Q2 2025 | 2025-06-30 | $205.4M | $63.8M | +45.05% |
| Q1 2025 | 2025-03-31 | $109.3M | −$57.7M | −34.56% |
| Q4 2024 | 2024-12-31 | $142.9M | −$55.2M | −27.88% |
| Q3 2024 | 2024-09-30 | $116.0M | −$107.0M | −47.99% |
| Q2 2024 | 2024-06-30 | $141.6M | −$109.4M | −43.59% |
| Q1 2024 | 2024-03-31 | $167.0M | −$110.5M | −39.82% |
| Q4 2023 | 2023-12-31 | $198.1M | −$101.2M | −33.82% |
| Q3 2023 | 2023-09-30 | $223.0M | $16.6M | +8.07% |
| Q2 2023 | 2023-06-30 | $251.0M | $26.4M | +11.74% |
| Q1 2023 | 2023-03-31 | $277.5M | $43.3M | +18.47% |
| Q4 2022 | 2022-12-31 | $299.4M | $56.8M | +23.40% |
| Q3 2022 | 2022-09-30 | $206.4M | −$52.3M | −20.21% |
| Q2 2022 | 2022-06-30 | $224.6M | −$50.5M | −18.36% |
| Q1 2022 | 2022-03-31 | $234.3M | −$58.7M | −20.03% |
| Q4 2021 | 2021-12-31 | $242.6M | $166.7M | +219.58% |
| Q3 2021 | 2021-09-30 | $258.6M | — | — |
| Q2 2021 | 2021-06-30 | $275.1M | — | — |
| Q1 2021 | 2021-03-31 | $292.9M | — | — |
| Q4 2020 | 2020-12-31 | $75.9M | — | — |
Vor Biopharma total assets trends
Over the last five fiscal years, Vor Biopharma's total assets increased from $75.9M to $464.1M, a change of $388.2M. The latest reported quarter, Q2 2026, shows $481.1M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vor Biopharma source filings ↗